Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Apo-nefazodone
2. Dutonin
3. Lin-nefazodone
4. Menfazona
5. Nefadar
6. Nefazodone
7. Rulivan
8. Serzone
1. 82752-99-6
2. Nefazodone Hcl
3. Serzone
4. Dutonin
5. Menfazona
6. Rulivan
7. Reseril
8. Bmy 13754
9. Nefazodone (hydrochloride)
10. 1-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1h-1,2,4-triazol-5(4h)-one Hydrochloride
11. Bmy-13754
12. Mj-13754-1
13. Mj 13,754-1
14. Nefadar
15. 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3h-1,2,4-triazol-3-one Hydrochloride
16. Chebi:7495
17. 27x63j94gr
18. Nsc-760344
19. 1-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta(sup 2)-1,2,4-triazolin-5-one Monohydrochloride
20. Bmy-13754-1
21. Dsstox_cid_26088
22. Dsstox_rid_81328
23. Dsstox_gsid_46088
24. 3h-1,2,4-triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, Monohydrochloride
25. 1-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-ethyl-4-(2-phenoxyethyl)-4,5-dihydro-1h-1,2,4-triazol-5-one Hydrochloride
26. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;hydrochloride
27. Smr000449297
28. Cas-82752-99-6
29. Nefazodone Hydrochloride [usan]
30. Ncgc00165846-02
31. Unii-27x63j94gr
32. Sr-01000759312
33. Serzone (tn)
34. Mfcd00935760
35. Nefazodone Hydrochloride [usan:usp]
36. 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3h-1,2,4-triazol-3-one Hydrochloride
37. Schembl41119
38. Mls000758241
39. Mls000759458
40. Mls001401457
41. Nefazodone Hydrochloride (usp)
42. Nefazodone Hydrochloride- Bio-x
43. Chembl1200492
44. Dtxsid8046088
45. Hy-b1396
46. Tox21_111735
47. Tox21_113574
48. Nefazodone Hydrochloride [mi]
49. S5398
50. Akos015846321
51. Tox21_111735_1
52. Ac-1373
53. Ccg-100923
54. Cs-4860
55. Ks-1088
56. Nc00173
57. Nsc 760344
58. Nefazodone Hydrochloride [mart.]
59. Ncgc00165846-04
60. Nefazodone Hydrochloride [usp-rs]
61. Nefazodone Hydrochloride [who-dd]
62. 3h-1,2,4-triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, Monohydrochloride
63. Bn164641
64. B7183
65. Ft-0601548
66. Nefazodone Hydrochloride [orange Book]
67. D00819
68. Nefazodone Hydrochloride [usp Impurity]
69. Nefazodone Hydrochloride [usp Monograph]
70. T72976
71. Nefazodone Hydrochloride, >=98% (hplc), Solid
72. 752n996
73. A840427
74. Sr-01000759312-6
75. Q27107509
76. Nefazodone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
77. Nefazodone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
78. 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3h-1,2,4-triazol-3-one Monohydrochloride
79. 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-2h-1,2,4-triazol-3(4h)-one Hydrochloride
80. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one Hydrochloride;nefazodone Hcl
81. 2-{3-[4-(3-chloro-phenyl)-piperazin-1-yl]-propyl}-5-ethyl-4-(2-phenoxy-ethyl)-2,4-dihydro-[1,2,4]triazol-3-one Hydrochloride
Molecular Weight | 506.5 g/mol |
---|---|
Molecular Formula | C25H33Cl2N5O2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 505.2011307 g/mol |
Monoisotopic Mass | 505.2011307 g/mol |
Topological Polar Surface Area | 51.6 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 649 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Nefazodone hydrochloride |
Drug Label | Nefazodone hydrochloride tablets USP are an antidepressant for oral administration with a chemical structure unrelated to selective serotonin reuptake inhibitors, tricyclics, tetracyclics, or monoamine oxidase inhibitors (MAOI).Nefazodone hydrochlori... |
Active Ingredient | Nefazodone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 250mg; 150mg; 100mg; 50mg |
Market Status | Prescription |
Company | Ranbaxy; Teva; Dr Reddys Labs |
2 of 2 | |
---|---|
Drug Name | Nefazodone hydrochloride |
Drug Label | Nefazodone hydrochloride tablets USP are an antidepressant for oral administration with a chemical structure unrelated to selective serotonin reuptake inhibitors, tricyclics, tetracyclics, or monoamine oxidase inhibitors (MAOI).Nefazodone hydrochlori... |
Active Ingredient | Nefazodone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 250mg; 150mg; 100mg; 50mg |
Market Status | Prescription |
Company | Ranbaxy; Teva; Dr Reddys Labs |
Serotonin 5-HT2 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes. (See all compounds classified as Serotonin 5-HT2 Receptor Antagonists.)
Serotonin and Noradrenaline Reuptake Inhibitors
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Nefazodone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nefazodone Hydrochloride, including repackagers and relabelers. The FDA regulates Nefazodone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nefazodone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nefazodone Hydrochloride supplier is an individual or a company that provides Nefazodone Hydrochloride active pharmaceutical ingredient (API) or Nefazodone Hydrochloride finished formulations upon request. The Nefazodone Hydrochloride suppliers may include Nefazodone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Nefazodone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nefazodone Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Nefazodone Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Nefazodone Hydrochloride DMFs exist exist since differing nations have different regulations, such as Nefazodone Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nefazodone Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Nefazodone Hydrochloride USDMF includes data on Nefazodone Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nefazodone Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nefazodone Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nefazodone Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nefazodone Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nefazodone Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nefazodone Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nefazodone Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nefazodone Hydrochloride suppliers with NDC on PharmaCompass.
Nefazodone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nefazodone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nefazodone Hydrochloride GMP manufacturer or Nefazodone Hydrochloride GMP API supplier for your needs.
A Nefazodone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Nefazodone Hydrochloride's compliance with Nefazodone Hydrochloride specifications and serves as a tool for batch-level quality control.
Nefazodone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Nefazodone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nefazodone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Nefazodone Hydrochloride EP), Nefazodone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nefazodone Hydrochloride USP).
LOOKING FOR A SUPPLIER?